INDUSTRIENS PENSIONSFORSIKRING v. BECTON, DICKINSON AND COMPANY, et al
Case Number:
2:20-cv-02155
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
-
January 19, 2024
Becton Investors Get Initial OK Of $85M Deal Over Recall
A magistrate judge granted preliminary approval to an $85 million settlement a class of Becton Dickinson investors reached with the medical tech company over securities fraud claims that it hid regulatory problems regarding sales of its Alaris infusion pump, which Becton recalled in 2020.
-
December 21, 2023
Becton Investors Seek OK Of $85M Deal Over Alaris Recall
A class of Becton Dickinson investors asked a New Jersey federal judge Thursday for his initial blessing on an $85 million settlement resolving securities fraud claims that the medical technology maker hid looming regulatory setbacks affecting the sales of its Alaris infusion pump, which Becton voluntarily recalled in 2020.
-
August 03, 2023
Becton Investors Get Cert. In Securities Suit Over Pump Recall
A New Jersey federal judge on Thursday certified a group of Becton Dickinson & Co. investors who accused the medical technology maker of hiding looming regulatory hurdles impacting sales of its Alaris infusion pump, finding the investors have shown that the question of individual damages calculations won't overwhelm common questions affecting the class.
-
January 18, 2023
Becton Dickinson Investor Seeks Cert. In Pump Recall Suit
An investor in medical technology maker Becton Dickinson and Co. has asked a Newark federal judge to certify a proposed class of shareholders in a suit alleging it concealed looming regulatory hurdles affecting sales of one of its key products.
-
August 12, 2022
Becton's Former CEO And CFO Escape Securities Suit
The former chief executive officer and onetime chief financial officer at Becton Dickinson & Co. have dodged a proposed class action alleging the company misled investors about its Alaris infusion pumps, but new allegations from confidential witnesses will keep the suit in play against the business and its current leader, a New Jersey federal judge has ruled.
-
September 16, 2021
Becton Beats FDA Approval Claims In Securities Suit
A New Jersey federal judge has nixed class claims that medical technology manufacturer Becton Dickinson & Co. hid that changes to its Alaris infusion pumps needed clearance through the U.S. Food and Drug Administration's 510(k) process, saying an investor failed to show the company believed such approval was necessary.
-
June 09, 2020
Kessler Topaz Named Lead Counsel In Becton Securities Suit
Kessler Topaz Meltzer & Check LLP was appointed lead counsel Tuesday in a proposed New Jersey federal court securities class action accusing medical technology manufacturer Becton Dickinson & Co. of failing to disclose software issues with its medical devices.
-
April 28, 2020
3 Firms Vie For Lead In Becton Securities Suit
Kessler Topaz Meltzer & Check LLP, The Rosen Law Firm PA and Glancy Prongay & Murray LLP each fought for the lead counsel role Monday in a proposed securities class action accusing medical technology manufacturer Becton Dickinson & Co. of failing to disclose software issues with its medical devices.
-
February 28, 2020
Becton Hit With Stock Suit Following $59M Pump Recall
Medical tech producer Becton Dickinson and Co. was hit with a proposed securities class action that accuses the company and its executives of failing to disclose software issues with a medical device it makes, problems that investors say led to a stock price drop after the company eventually admitted them.